Get the Daily Brief
Latest Biotech News
Eli Lilly Expands Gene Editing Portfolio with Verve Acquisition
Eli Lilly announced the acquisition of gene-editing biotech Verve Therapeutics for up to $1.3 billion, acquiring full rights to Verve's PCSK9-targeting program aimed at one-time cardiovascular...
Breakthroughs in AI-Driven Protein Design and Drug Discovery
Innovative AI methodologies are transforming protein design and drug development. EMBL researchers introduced AlphaDesign, an AI framework advancing de novo protein creation with applications in...
Novel Cancer Therapeutics from Biotech and Academic Collaborations
Recent collaborations and discoveries are advancing cancer treatments. Mount Sinai’s OCCAM Immune and Cancer Research Institute joined forces to enhance immunotherapy outcomes through integrated...
Advanced Diagnostic Innovations Enhance Early Disease Detection
Emerging diagnostic technologies promise to revolutionize early disease detection and monitoring. King’s College London developed a nanoneedle patch enabling painless, repeated molecular profiling...
AI and Machine Learning Transform Biotech and Healthcare Workflows
Artificial intelligence continues reshaping biotech research and medical diagnostics. New frameworks for improved prompt training—such as Requirement-Oriented Prompt Engineering—help users...
Environmental and Microbial Studies Tackle Pollution and Ecosystem Dynamics
Cutting-edge research is addressing environmental challenges via microbial and ecological discoveries. Italian scientists identified bacteria in PFAS-contaminated Veneto soil capable of degrading...
Neonatal and Pediatric Advances in Disease Treatment and Diagnosis
Pediatric research yields new insights into disease mechanisms and treatments. Automated EEG analysis offers early outcome predictions for newborns with hypoxic-ischemic encephalopathy treated...
Biotech Industry Mergers, Funding, and Regulatory Updates
The biotech sector experiences notable deal activity and regulatory changes. Supernus Pharmaceuticals announced a $795 million acquisition of Sage Therapeutics, integrating its postpartum...
Climate Change and Urbanization Impact on Health and Environment
Research highlights the multifaceted effects of climate and urbanization on health and ecosystems. Studies reveal rising nighttime temperatures increase health risks such as premature births and...
Building Biosecurity through Government-Industry Partnerships
The 2025 BIO International Convention highlighted the critical need for sustained collaboration between government agencies and the biotech industry to enhance America's biodefense capabilities....
Elevidys Gene Therapy Liver Toxicity and DMD Patient Deaths
Sarepta Therapeutics has faced a second patient death from acute liver failure linked to its Duchenne muscular dystrophy gene therapy, Elevidys. Both fatalities involved non-ambulatory patients....
AI Advancements in Drug Discovery and Diagnostic Testing
Recent expansions of artificial intelligence applications in biopharma encompass drug discovery, precision medicine, and diagnostic tools. Innovations include machine learning frameworks improving...
Sage Therapeutics Acquisition by Supernus Pharmaceuticals
Supernus Pharmaceuticals is acquiring Sage Therapeutics for up to $795 million, securing rights to Sage's postpartum depression drug Zurzuvae. The acquisition follows Sage's decline from a $9...
Breakthroughs in Nanoneedle Technology for Painless Diagnostics
Scientists at King's College London developed a cutting-edge nanoneedle patch featuring tens of millions of microscopic silicon-based needles. This technology is poised to revolutionize...
AI and Imaging Genomics Integrate for Precision Medicine
Imaging genomics, combining multi-modal imaging technologies with omics data, is evolving with the aid of AI and deep learning to decode complex disease mechanisms at molecular levels. This...
Advancements in Epigenetics and Pulmonary Disease Research
Recent studies shed light on epigenetic regulation mechanisms in persistent pulmonary hypertension of the newborn (PPHN) and male reproductive toxicity linked to PFAS exposure. Researchers...
Innovations in Cancer Therapy and Diagnostics
Cutting-edge research spans multiple fronts including an algorithm, TACIT, that accelerates cell type classification in multiplexed imaging; multifunctional nanoparticles allowing bimodal...
Regulatory Updates and Market Activity in Biotech
Regulatory agencies continue to adjust resource allocations and policy frameworks impacting drug development timelines, oversight of lab-developed tests, and clinical trial acceleration, as...
Environmental and Public Health Insights Affecting Biotech and Healthcare
Emerging research reveals environmental factors impacting human and ecosystem health, from PFAS-degrading bacteria discovered in Veneto soil to artificial light extending urban growing seasons...
Sarepta halts Duchenne gene therapy after second liver failure death
Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients following a second fatal case of acute liver failure (ALF). Both...